Orofacial Pain and Temporomandibular Joint Disorders, Eastman Institute for Oral Health, University of Rochester, 625 Elmwood Avenue, Rochester, NY, 14620, USA.
Department of Diagnostic Sciences, Rutgers School of Dental Medicine, NJ, USA.
Arch Oral Biol. 2019 Jun;102:193-198. doi: 10.1016/j.archoralbio.2019.04.012. Epub 2019 Apr 30.
The objective of this study was to assess the effect of Porphyromonas gingivalis lipopolysaccharide (PG LPS) on acute pain-related behaviour induced in rats and to measure its impact on the levels of pro-inflammatory cytokines (IL-1β, IL-6) and anti-inflammatory (IL-10) cytokines.
The Brennan model was used to induce acute pain like signs in rats' hind paw. Twenty-four hours following the surgery the rats were divided into 5 groups and the affected paws were injected with 0.2 m l of one of three commercialized forms PG LPS doses (high - 1 mg/ml, medium - 0.6 mg/m l and low - 0.2 mg/m l), diclofenac sodium (1 mg/kg) or saline. Tactile allodynia, mechanical hyperalgesia, body temperature and paw swelling were assessed at baseline, 24 h postoperatively and 2 h after the paw injection. The affected and contra-lateral paw tissue was assessed for the mentioned above cytokines levels employing enzyme-linked immunosorbent assay.
This study may suggest that PG LPS can reduce pain like behaviour via increased levels of anti-inflammatory cytokine IL-10 (5900 ± 748, p < 0.05). The high PG LPS dose and diclofenac reduced the tactile allodynia and mechanical hyperalgesia significantly (42.2 ± 4 and1.6 ± 0.3, p < 0.05). PG LPS high dose increase IL-10 levels while diclofenac reduces IL-1β levels significantly (5900 ± 748 and 1760 ± 271.2). The LPS administration had no effect on paw swelling and did not increase rat's body temperature.
The results demonstrated that PG LPS local application could possess anti- nociceptive properties, which at least in part is mediated by an increase in IL-10 levels.
本研究旨在评估牙龈卟啉单胞菌脂多糖(PG LPS)对大鼠急性痛相关行为的影响,并测量其对促炎细胞因子(IL-1β、IL-6)和抗炎细胞因子(IL-10)水平的影响。
采用 Brennan 模型诱导大鼠后爪出现急性痛相关征象。手术后 24 小时,将大鼠分为 5 组,在受影响的爪子中注射三种商业化 PG LPS 剂量(高剂量-1mg/ml、中剂量-0.6mg/ml 和低剂量-0.2mg/ml)、双氯芬酸钠(1mg/kg)或生理盐水 0.2ml。在基线、术后 24 小时和爪子注射后 2 小时评估触觉过敏、机械性痛觉过敏、体温和爪子肿胀。采用酶联免疫吸附试验检测受影响和对侧爪子组织中上述细胞因子水平。
本研究表明,PG LPS 可通过增加抗炎细胞因子 IL-10 的水平来减轻痛觉样行为(5900±748,p<0.05)。高剂量 PG LPS 和双氯芬酸钠显著减轻触觉过敏和机械性痛觉过敏(42.2±4 和 1.6±0.3,p<0.05)。高剂量 PG LPS 增加 IL-10 水平,而双氯芬酸钠显著降低 IL-1β 水平(5900±748 和 1760±271.2)。LPS 给药对爪子肿胀没有影响,也不会增加大鼠的体温。
研究结果表明,PG LPS 局部应用可能具有抗伤害感受特性,至少部分是通过增加 IL-10 水平介导的。